Altogether, the cauda equina GBM lesion was found to have genetic perturbations in multiple pathways implicated in GBM development,2,4 including the Rb pathway (CDK4), the PI3K pathway (PIK3R1), the p53 pathway (MDM2), and telomerase activation (TERT). The gene discussed is TP53; the disease is glioblastoma.